PCN72 COST-UTILITY ANALYSIS OF GEFITINIB VERSUS DOCETAXEL IN A MEXICAN PUBLIC INSTITUTION

Authors:
  • PAP Anaya
    P Anaya
  • RLRj López
    Rj López
  • APAc Polanco
    Ac Polanco

Abstract
No abstract available